Home/Filings/4/0001048477-25-000025
4//SEC Filing

Guyer Charles Greg 4

Accession 0001048477-25-000025

CIK 0001048477other

Filed

Mar 6, 7:00 PM ET

Accepted

Mar 7, 4:06 PM ET

Size

4.9 KB

Accession

0001048477-25-000025

Insider Transaction Report

Form 4
Period: 2025-03-06
Guyer Charles Greg
EVP, Chief Technical Officer
Transactions
  • Sale

    Common Stock

    2025-03-06$71.28/sh7,034$501,35587,655 total
Footnotes (1)
  • [F1]The price in column 4 is the weighted average price. The price actually received ranged from $71.276 to $71.285. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.

Issuer

BIOMARIN PHARMACEUTICAL INC

CIK 0001048477

Entity typeother

Related Parties

1
  • filerCIK 0001811096

Filing Metadata

Form type
4
Filed
Mar 6, 7:00 PM ET
Accepted
Mar 7, 4:06 PM ET
Size
4.9 KB